Table 3.
This table shows underlying conditions for all patients (with or without OD).
Olfactory dysfunction (OD) |
||||
---|---|---|---|---|
Total (%) | None n = 104 (%) |
Positive n = 207 (%) |
p-Values | |
Past Medical History (Hx) | ||||
None | 167 (53.6) | 41 (39.4) | 126 (37.6) | *.000 |
Positive | 144 (46.3) | 63 (60.6) | 81 (39.1) | |
Diabetes | ||||
None | 245 (78.8) | 80 (78.9) | 165 (78.7) | .571 |
Positive | 66 (21.2) | 24 (23) | 42 (21.3) | |
Hyperlipidemia | ||||
None | 306 (98.4) | 101 (97) | 205 (99) | .204 |
Positive | 5 (1.6) | 3 (3) | 2 (1) | |
Hypertension | ||||
None | 258 (83.0) | 78 (75) | 180 (87) | *.008 |
Positive | 53 (17.0) | 26 (25) | 27 (13.0) | |
Liver Diseases | ||||
None | 309 (99.4) | 102 (98) | 207 (100.0) | *.045 |
Positive | 2 (0.6) | 2 (2) | 0 (0.0) | |
Kidney Diseases | ||||
None | 302 (97.1) | 96 (92.3) | 206 (99.5) | *.000 |
Positive | 9 (2.9) | 8 (7.7) | 1 (0.5) | |
Hyperthyroidism | ||||
None | 300 (96.8) | 100 (96.2) | 200 (97.1) | .660 |
Positive | 10 (3.2) | 4 (3.8) | 6 (2.9) | |
Hypothyroidism | ||||
None | 307 (98.7) | 102 (98.1) | 205 (99) | .480 |
Positive | 4 (1.3) | 2 (1.9) | 2 (1) | |
Pulmonary Disease | ||||
None | 302 (97.1) | 96 (92.3) | 206 (99.5) | *.000 |
Positive | 9 (2.9) | 8 (7.7) | 1 (0.5) | |
Cardiovascular Diseases | ||||
None | 288 (92.6) | 88 (84.6) | 200 (96.6) | *.000 |
Positive | 23 (7.4) | 16 (15.4) | 7 (3.4) | |
Cancer | ||||
None | 308 (99.0) | 101 (97.1) | 207 (100.0) | *.014 |
Positive | 3 (1.0) | 3 (2.9) | 0 (0.0) | |
Asthma | ||||
None | 293 (94.2) | 93 (89.4) | 200 (96.6) | *.010 |
Positive | 18 (5.8) | 11 (10.6) | 7 (3.4) | |
Family history of COVID-19 | ||||
None | 218 (70.1) | 89 (85.6) | 129 (63.3) | *.000 |
Positive | 91 (29.9) | 15 (14.4) | 76 (36.7) |
A history of underlying conditions was significantly higher in non-OD patients (p < .05). Hypertension and history of COVID-19 in family members were significantly higher in non-OD and OD patients, respectively. A history of cancer, asthma, liver, kidney, pulmonary, and cardiovascular diseases was more prominent in Non-OD patients (p < .05). The Asterisks in the table denote statistically significant p-values.